Clinical Trial Update: Self-control Trial to Evaluate the Role of Aprepitant in the Prophylaxis of Post-lumbar-punture-headache (PLPH) [Phase 4]

View source ↗

Summary

Phase 4 clinical trial update investigating aprepitant (Emend) for prevention of post-lumbar-puncture headache in leukemia and lymphoma patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leukemia
• Lymphoma

Drugs mentioned

• EMEND (aprepitant)

Snippet

Sponsor: Sun Yat-sen University | Conditions: Leukemia, Lymphoma | Phase 4 | Status: UNKNOWN